Jennison Associates LLC Has $45.10 Million Stock Holdings in Celldex Therapeutics, Inc. (NASDAQ:CLDX)
Jennison Associates LLC trimmed its position in Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 16.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,329,095 shares of the biopharmaceutical company’s stock after selling 252,995 shares during the quarter. Jennison […]
More Stories
How the US Can Adjust to Middle East Oil Disruptions
By Kevin Stocklin The U.S.–Israeli war with Iran has brought heightened volatility to energy and equity markets, with the price...
Shooting For Ginny & Georgia Season 4 Has Ended: Release Date and Cast Updates
The Netflix American drama Ginny & Georgia, which premiered on Netflix on February 24, 2021, has received huge appreciation and...
Content Marketing For Startups: Strategies, Benefits, and Mistakes to Avoid
With the growing number of startups, it is becoming very difficult to appear in the search results. If you are...
The Search Monitor Review 2026: Pricing and Alternatives
Want to know which competitors are misusing your brand name without your permission? Or are they trying to waste your...
Kelly Osbourne Movies and TV Shows: Appearance at the 2026 BRIT Awards
Kelly Osbourne is popularly known as the daughter of the late English singer and songwriter, John Michael “Ozzy” Osbourne. She...
Moon Mission on Track for April 1 Launch: NASA
By T.J. Muscaro CAPE CANAVERAL, Fla.—NASA leadership confirmed on March 12 that they were targeting 6:24 p.m. on April 1...